Clinical Trial Update: RSV Vaccination to Reduce Recurrent AECOPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial led by the Chinese University of Hong Kong is evaluating an RSV vaccine to reduce recurrent acute exacerbations of chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Respiratory Syncytial Virus Infection

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: COPD, RSV | Phase 4 | Status: NOT_YET_RECRUITING